Your browser cookies must be enabled in order to apply for this job. Please contact if you need further instruction on how to do that.

Summer Undergraduate Internship - Medicinal Chemistry

Summer Internships | Berkeley, CA | Internship

Job Description

This is a summer internship for undergraduate students who will still be in an undergraduate program in the Fall of 2018.

The internship in Medicinal Chemistry will support our efforts in the synthesis of potential drug candidates. The intern will conduct multi-step organic syntheses of milligram to gram quantities of target compounds, as well as key intermediates, using established procedures. Under the close supervision of a scientist, the intern’s primary duties will be the synthesis, purification, and characterization of selected organic compounds to support our efforts in one of our drug discovery projects. The intern is expected to have completed a minimum of one year of Organic Chemistry, with significant laboratory experience, demonstrating the ability to work safely. The intern will have the opportunity to contribute to the drug discovery process for a selected target in oncology, inflammation, or metabolic disease by participating in project meetings, preparing compounds for testing, and learning about medicinal chemistry and modern methods of drug discovery in an industrial setting.  The ideal candidate will have just completed the sophomore or junior year and will be interested in pursuing a career in Biotechnology or an advanced degree in Chemistry (rather than someone interested in an advanced degree in Medicine). 

A final presentation is given for the department and then at the company Research Meeting.

Company Description:

Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company utilizes its proprietary discovery platform to successfully develop a portfolio of competitively differentiated clinical and preclinical stage compounds in a number of therapeutic areas. Plexxikon’s most advanced program, Zelboraf™ (vemurafenib) was the first oral targeted therapy to be approved for the treatment of both metastatic and unresectable melanomas.   Plexxikon's demonstrated capability in discovery and early development uniquely positions the company to develop multiple commercial franchises for different therapeutic indications, and to create significant value for Plexxikon, Daiichi Sankyo and its collaborators.

Plexxikon's novel discovery approach, combined with experienced management and scientific teams, a broad network of scientific and clinical experts, and partnerships supporting later stage development, have been key drivers of the company's success since it began operations in 2001.  Plexxikon is a small business with approximately 70 employees based in Berkeley, California.

Summer 2018 will be Plexxikon’s fourteenth year of participation in the undergraduate summer internship program, having experienced highly successful results in each previous year.   This is a paid internship that will run from Friday, June 1 – Friday, August 11, 2018. Our office is just off I80 at University Avenue.   Please find out more at: